CREB1 and Alzheimer disease: Compelling data suggest that microglial activation as well as decreased CREB/BDNF to be important activators for oxidative stress and inflammatory cytokines in AD, autism, and neurodegenerative disease, leading to cognitive and learning impairment [7, 56–58].